-
Execitalopram oxalate tablets, a new Kangenbei 3.1 drug, has been approved for production
Time of Update: 2020-04-03
Kangenbei's approved production of new spiritual drugs can enrich the company's existing product line and play a positive role in future performance.
-
Coating standard: the preparation of green building materials product catalog started in an all-round way
Time of Update: 2020-04-03
Core tips: in order to guide the expansion of green building materials consumption, promote the structural adjustment of building materials products, accelerate the industrial
-
In 2020, we will work together with our motherland to help China's pharmaceutical industry become a pioneer in reform
Time of Update: 2020-01-26
President Xi said in his new year's message, "2020 is a year of milestone significance and decisive victory in poverty alleviation." The national medical security work conference
-
268 drugs removed from medical insurance (list attached
Time of Update: 2020-01-08
On January 6, Shandong provincial drug centralized purchase network released the notice on adjusting the medical insurance attributes of online products by drug purchase platform
-
How can drug companies bear the pressure when the supplement of local medical insurance catalogue is cancelled
Time of Update: 2020-01-07
Some insiders said that under the circumstances of canceling the supplement of local medical insurance catalogue, pharmaceutical enterprises have two ways to bear pressure.
-
What is the development trend of Chinese herbal medicine? It is clear at a glance from the implementation of the National Medical Insurance Catalogue in 2019
Time of Update: 2020-01-06
Chinese Herbal Pieces refer to Chinese herbal medicines and processed products which can be directly used for dispensing or preparation under the guidance of the theory of Chinese
-
What is the development trend of Chinese herbal medicine? It is clear at a glance from the implementation of the National Medical Insurance Catalogue in 2019
Time of Update: 2020-01-06
Chinese Herbal Pieces refer to Chinese herbal medicines and processed products which can be directly used for dispensing or preparation under the guidance of the theory of Chinese
-
Official implementation of medical insurance catalogue local supplement channel blocked
Time of Update: 2020-01-06
The new version of the medical insurance catalogue has been officially implemented since January 1, 2020
One of the key points of the new edition is to cancel
-
What is the development trend of Chinese herbal medicine? It is clear at a glance from the implementation of the National Medical Insurance Catalogue in 2019
Time of Update: 2020-01-03
Original: Medical vernacular Introduction: Chinese herbal pieces are an important carrier of Chinese medicine culture
In the supporting documents of 2019 national
-
What is the development trend of Chinese herbal medicine? It is clear at a glance from the implementation of the National Medical Insurance Catalogue in 2019
Time of Update: 2020-01-03
Chinese herbal pieces are an important carrier of Chinese medicine culture
In the supporting documents of 2019 national medical insurance catalog, the supporting
-
The new version of the medical insurance catalogue has been implemented on January 1, and 97 negotiated drugs have officially entered the medical insurance
Time of Update: 2020-01-02
Moreover, some provinces, such as Jiangxi, etc Notice has been sent, and the key monitored drugs must be withdrawn from the catalogue at one time.
-
The new version of medical insurance catalog is officially implemented! Good news for chronic patients
Time of Update: 2020-01-02
Hubei Province has officially implemented the new version of the medical insurance drug catalog since January 1.
-
No more local supplements
Time of Update: 2020-01-02
From January 1, 2019 version of the national medical insurance catalogue will be implemented soon, and a large number of varieties will face challenges
Compared
-
It is normal for drugs to be transferred out of the medical insurance catalogue, and 352 kinds of drugs have been transferred out
Time of Update: 2019-12-31
[industry trends of pharmaceutical network] recently, Beijing Municipal Medical Security Bureau announced the notice of Beijing Municipality on the adjustment of the reimbursement
-
352 drugs transferred out of Beijing Medical Insurance catalogue
Time of Update: 2019-12-27
352 drugs were transferred out of the medical insurance catalogue of Beijing; meanwhile, the medical insurance catalogue of Hebei Province was circulated in the industry
-
State Food and Drug Administration's latest notice: 1418 medical devices and reagents are exempted from clinical trials
Time of Update: 2019-12-26
Table 2 exemption quantity of different types of medical devices in the current exemption catalogue There are 416 exempted in vitro diagnostic reagent products, involving 13 in vitro diagnostic reagent product categories (11 class II products, 3 class III products).
-
Another 346 kinds of drugs have been removed from medical insurance. What should pharmaceutical companies do in the future
Time of Update: 2019-12-21
[industry trends of pharmaceutical network] recently, Sichuan Medical Security Bureau issued a document
Since January 1, 2020, the basic medical insurance, work-related
-
Sichuan Province removed 346 kinds of drugs from the list of Medicare drugs
Time of Update: 2019-12-20
The news that 346 products were moved out of Sichuan Medical Insurance warned the medical representatives behind them: it's time to move and make plans
Recently, Sichuan
-
The local medical insurance catalog has been adjusted, and a large number of drugs will be out
Time of Update: 2019-12-17
[pharmaceutical network industry trends] following the release of the national medical insurance catalog, drug price reduction has become a major trend, and many patients
-
It is an inevitable trend that the purchase of the second tire will be expanded to reduce the drug price at one's own expense
Time of Update: 2019-12-16
In addition to acarbose and solanesin, adefovir dipivoxil, tadalafil and enrisentan are all self funded drugs, which means that the war of volume purchase has extended to the price of drugs outside the national health insurance catalog.
